文献速递小儿麻醉

放射科人员实施鼻内右美托咪定镇静用于儿科MRI的回顾性观察研究

Intranasal dexmedetomidine sedation for paediatric MRI by radiology personnel: A retrospective observational study.
PubMed 文献 · Eur J Anaesthesiol · 2022-12-22

MRI成功率为93%(95%CI 91-94%),无重大不良事件,轻微问题发生率0.2%(95%CI 0-0.7%),5例(0.4%)心率低于预设下限。结论认为该方案耐受良好且对图像质量干扰小。

要点

  • 鼻内右美托咪定镇静下儿科MRI成功率达93%,无重大不良事件。
  • 放射科人员可在无麻醉人员在场时安全实施该镇静方案。
  • 给药后心率与平均动脉压下降在可接受范围内,无需干预。

核心结论

  • 无麻醉人员即时在场的鼻内右美托咪定镇静用于儿科MRI耐受良好,对图像质量干扰极小。

主要发现

  • MRI成功率为93%(95%CI 91-94%)。
  • 无重大不良事件记录,轻微问题总发生率为0.2%(95%CI 0-0.7%)。
  • 5例儿童在右美托咪定给药后心率低于预设下限(0.4%;95%CI 0.1-0.9%)。
  • 给药后心率和平均动脉压显著下降,但在可接受范围内,无需干预。

关键数值与推荐

  • 鼻内右美托咪定初始剂量为4 μg/kg,必要时追加第二剂2 μg/kg。
  • 记录图像质量、不良事件、心率、脉搏血氧饱和度和无创血压。

临床怎么用

  • 在缺乏儿科麻醉服务的机构,可由放射科人员按方案实施鼻内右美托咪定镇静以完成儿科MRI。
  • 需监测心率、血氧饱和度和血压,并设定心率下限以及时识别心动过缓。

局限性

  • 为单中心回顾性观察研究,非随机对照设计。
  • 试验注册为回顾性注册(NCT05163704)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: MRI often requires sedation or anaesthesia to ensure good image quality in paediatric patients. Access to paediatric anaesthesia services is, however, a limiting factor for effective paediatric MRI service, and alternative sedation methods are, therefore, warranted. OBJECTIVE: To investigate the efficacy and safety of an intranasal dexmedetomidine sedation program for paediatric MRI, without immediate presence of anaesthesia personnel. DESIGN: Single institution retrospective observational study. SETTING: Tertiary care paediatric hospital. PATIENTS: Children 0 to 12 years, ASA risk class 1 or 2 with heart rate within age-appropriate limit. INTERVENTION: Radiology personnel administered an initial dose of intranasal dexmedetomidine of 4 μg kg -1 followed by a second dose of 2 μg kg -1 to the patients if needed. Recordings of image quality, critical events, heart rate, pulse oximetry saturation and noninvasive blood pressure before and after dexmedetomidine administration were made. MAIN OUTCOME MEASURES: Changes in haemodynamic and respiratory data before vs. after intranasal dexmedetomidine were analysed for changes, and the incidence of critical events was evaluated as well as rate of successful MRI scans. RESULTS: One thousand and ninety-one MRIs under intranasal dexmedetomidine sedation were included (mean age 34 months, 95% confidence interval (CI), 33 to 36, 599 male individuals). A success rate of 93% (95% CI, 91 to 94%) was found. No major critical events were recorded, total incidence of minor issues was 0.2% (95% CI, 0 to 0.7%). Five children had a heart rate under a preset minimal limit after dexmedetomidine (0.4%; 95% CI, 0.1 to 0.9%). Significant decreases in heart rate and mean arterial pressure, within acceptable limits not requiring intervention, was seen after dexmedetomidine administration. CONCLUSION: Intranasal dexmedetomidine sedation without immediate presence of anaesthesia personnel appears to be well tolerated and associated with minimal interference on MRI image quality. TRIAL REGISTRATION: clinicaltrials.org NCT05163704, retrospectively registered.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Karlsson J, Lewis G, Larsson P, et al. Intranasal dexmedetomidine sedation for paediatric MRI by radiology personnel: A retrospective observational study. Eur J Anaesthesiol. 2022. PMID: 36546479. doi:10.1097/EJA.0000000000001786

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。